Michel P Coleman mostly deals with Cancer, Demography, Relative survival, Breast cancer and Survival rate. His study on Cancer is covered under Internal medicine. His research in Demography intersects with topics in Epidemiology, Young adult, Gerontology, Colorectal cancer and Survival analysis.
His Survival analysis study integrates concerns from other disciplines, such as Global health and Socioeconomic status. His biological study spans a wide range of topics, including Liver cancer, Prostate cancer, Public health and Cancer survival. The various areas that Michel P Coleman examines in his Breast cancer study include Cervical cancer and Oncology.
His primary areas of study are Cancer, Demography, Internal medicine, Relative survival and Survival analysis. His research integrates issues of Surgery, Epidemiology and Incidence in his study of Cancer. Within one scientific family, Michel P Coleman focuses on topics pertaining to Breast cancer under Demography, and may sometimes address concerns connected to Cervical cancer and Lung cancer.
Michel P Coleman has researched Internal medicine in several fields, including Gynecology and Oncology. His research in Relative survival tackles topics such as Cancer survival which are related to areas like Socioeconomic inequalities. He has included themes like Social class and Adenocarcinoma in his Survival analysis study.
Cancer, Demography, Cancer registry, Internal medicine and Cancer survival are his primary areas of study. Breast cancer and Colorectal cancer are the core of his Cancer study. His Demography research incorporates elements of Public health surveillance, Public health, Net Survival and Relative survival.
His Relative survival research incorporates themes from Liver cancer and Survival rate, Surgery. His study in Cancer registry is interdisciplinary in nature, drawing from both Medical record, Family medicine, Data quality, International comparisons and Survival analysis. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Ovarian cancer and Pathology.
Michel P Coleman mainly focuses on Cancer, Demography, Cancer registry, Survival analysis and Breast cancer. His Cancer research is multidisciplinary, incorporating perspectives in Incidence, Oncology, Young adult, Public health and Pediatrics. His Demography study combines topics from a wide range of disciplines, such as Liver cancer, Relative survival, Lung cancer and Gerontology.
The study incorporates disciplines such as Survival rate, Surgery, Rural area, Esophageal cancer and Cancer prevention in addition to Relative survival. His work carried out in the field of Cancer registry brings together such families of science as Clinical trial, Health care, Cancer staging, Mortality rate and Data quality. Michel P Coleman focuses mostly in the field of Breast cancer, narrowing it down to topics relating to Cervical cancer and, in certain cases, Skin cancer, Global health, Gynecology and Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood.
The Lancet (2018)
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani;Hannah K Weir;Helena Carreira;Rhea Harewood.
The Lancet (2015)
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study
Roberta De Angelis;Milena Sant;Michel P Coleman;Silvia Francisci.
Lancet Oncology (2014)
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Michel P. Coleman;Manuela Quaresma;Franco Berrino;Jean Michel Lutz.
Lancet Oncology (2008)
An international association between Helicobacter pylori infection and gastric cancer
D Forman;M Coleman;Gui De Backer;J Eider.
The Lancet (1993)
Trends in cancer incidence and mortality
M P Coleman;J Estève;P Damiecki;A Arslan.
IARC scientific publications (1993)
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
MP Coleman;D Forman;H Bryant;J Butler.
The Lancet (2011)
Origins of socio-economic inequalities in cancer survival: a review
L. M. Woods;B. Rachet;M. P. Coleman.
Annals of Oncology (2006)
The global burden of women's cancers: a grand challenge in global health
Ophira M Ginsburg;Ophira M Ginsburg;Freddie Bray;Michel P Coleman;Verna Dnk Vanderpuye.
The Lancet (2017)
Cancer survival in China, 2003–2005: A population‐based study
Hongmei Zeng;Rongshou Zheng;Yuming Guo;Siwei Zhang.
International Journal of Cancer (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: